Operating profit EBITDA: azitrainc.com (AZTR)

Brandmark of Azitra Inc (AZTR)

Azitra, Inc. (AZTR) maintains a high level of authority in applying the skin microbiome to combat dermatological pathologies. The business model relies on outsourcing production and testing, thereby eliminating capital expenditures. The current quote prices in R&D costs and the distant timelines for therapy launch. Absolute operating profit reflects cash flow dynamics, where the value of 0.00 shows the current magnitude of this financial metric.

Profit before payment of interest, taxes and amortization: azitrainc.com (AZTR) for 11/23/2025 - 11/10/2026

Azitra - analytical breakdowns and key metrics (AZTR)

- stock value and consensus price forecast:
Market Chart Azitra Corporation|AZTR - Price Target Chart
- company stock exchange capitalization indicators:
Market Capitalization Azitra|AZTR - Enterprise Value
- book value of equity indicators:
Net Assets per Share Azitra|AZTR - Company Book Value|Capitalization to Book Value Ratio azitrainc.com|AZTR - Company Total Assets
- business debt structure and liquidity details:
Total Debt to Capital Azitra, Inc.|AZTR - Long-Term Debt to Equity Ratio|Current Liabilities to Equity Azitra Inc|AZTR - Company Aggregate Debts|Debts to Net Assets Azitra|AZTR - Company Long-Term Liabilities|Amount of Current Liabilities Azitra|Intermediate Coverage Ratio azitrainc.com
- company profitability and valuation multiples indicators:
AZTR - Net Profit|Projected Future Earnings Azitra, Inc.|AZTR - Price to Earnings Ratio|Future Price to Earnings Multiple azitrainc.com|AZTR - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio Azitra|AZTR - Profit before payment of interest, taxes and amortization|Earnings per share for the last 12 months Azitra|AZTR - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months azitrainc.com|AZTR - Net earnings per share growth this year|Consensus forecast of earnings per share growth for next year Azitra, Inc.
Summary company analytics:AZTR Azitra Corporation
Original product of azitrainc.com

Absolute operating profit measures the cash flow from core operations before interest and taxes, allowing for an assessment of real resource generation efficiency regardless of debt load. By analyzing the consolidated EBITDA of Azitra, Inc. (AZTR), an investor can see how the patent protection of Azitra, Inc. (AZTR) biotherapeutic software converts into high margins and future free cash flow growth.

Competitor analysis for Azitra, Inc.

Operating income before deduction of amortization Krystal Biotech Corp. (KRYS)|APGE - Profit before payment of interest, taxes and amortization|ARQT - Operating profit EBITDA|VCEL: Operating profit EBITDA|ORKA - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Sanara MedTech, Inc.|Operating profit before amortization DBVT (DBV Technologies SA)|Operating profit EBITDA SLSN|Operating profit EBITDA journeymedicalcorp.com (DERM)|Forte Biosciences - Operating profit before deduction of amortization|EMPG (Empro Group Inc.) - Profit before deduction of interest, taxes, depreciation and amortization|Sol-Gel - Operating profit EBITDA|Operating income before deduction of amortization AXIL Brands, Inc. AXIL|MDCX (Medicus Pharma Ltd.) - Operating profit before deduction of amortization|VRCA: Company profit before taxes, interest and amortization|Profit before payment of interest, taxes and amortization Hoth Therapeutics Inc.|BFRI: Income before deduction of interest, taxes and amortization|Operating profit EBITDA VYNE|Operating profit EBITDA sonomapharma.com (SNOA)|Quoin Pharmaceuticals Ltd. - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization DRMA|Elevai Labs - Operating profit EBITDA|Operating income before deduction of amortization Revance Therapeutics Inc. RVNC